ArticleThrombosis journal2024

Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban.

Liselotte Onelöv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.